Bright Minds Biosciences Inc. (CSE:DRUG)
Canada flag Canada · Delayed Price · Currency is CAD
51.79
-0.39 (-0.75%)
Apr 2, 2025, 11:52 AM EST

Bright Minds Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019
Market Capitalization
3687828107-
Upgrade
Market Cap Growth
3710.83%-19.09%-71.17%-73.71%--
Upgrade
Enterprise Value
310001985-
Upgrade
Last Close Price
52.181.472.158.5045.20-
Upgrade
PB Ratio
6.311.191.232.675.51-
Upgrade
P/TBV Ratio
6.241.191.232.675.52-
Upgrade
Debt / Equity Ratio
0.000.020.010.01--
Upgrade
Quick Ratio
125.5910.9224.168.0031.125.30
Upgrade
Current Ratio
126.1511.3224.268.1131.385.82
Upgrade
Return on Equity (ROE)
-3.35%-46.18%-86.02%-99.95%-85.94%-124.04%
Upgrade
Return on Assets (ROA)
-4.93%-25.19%-47.45%-57.32%-51.52%-61.70%
Upgrade
Return on Capital (ROIC)
-5.02%-26.53%-51.86%-61.21%-53.54%-76.64%
Upgrade
Earnings Yield
-0.29%-42.70%-90.90%-53.20%-8.09%-
Upgrade
Buyback Yield / Dilution
-29.26%-15.87%-50.58%-37.64%-148.42%-74.24%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.